Trials / Unknown
UnknownNCT05041725
The Impact of Remimazolam for Postoperative Sedation on the Left Ventricular Systolic Performance in Cardiac Surgery
The Impact of Remimazolam on the Left Ventricular Systolic Performance for Cardiac Surgery: a Speckle Tracking Analysis of the Left Ventricular Strain Using Transthoracic Echocardiography
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Konkuk University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study analyzes the impact of intraoperative Remimazolam infusion for postoperative sedation on the left ventricular global longitude strain (LV-GLS) patients undergoing cardiac surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam Injection [Byfavo] | Remimazolam injection and continuous infusion for postoperative sedation, 0.2 mg/kg for 1 min and continuous infusion of 1-2 mg/kg/hour |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-11-30
- Completion
- 2022-12-31
- First posted
- 2021-09-13
- Last updated
- 2021-09-13
Source: ClinicalTrials.gov record NCT05041725. Inclusion in this directory is not an endorsement.